John Townsend - 12 Jul 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
Chief Financial Officer
Signature
/s/ John Townsend
Issuer symbol
UNCY
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
3
Filing time
12 Jul 2021, 17:11:21 UTC
Next filing
26 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UNCY Employee Stock Option (right to buy) 12 Jul 2021 Common Stock 23,256 $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the stock options vest on March 1, 2022, and the remaining seventy-five percent (75%) of the stock options vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on March 1, 2025.